A carregar...
EGFR-Targeted Therapies in the Post-Genomic Era
Over ninety percent of head and neck cancers overexpress the epidermal growth factor receptor (EGFR). In diverse tumor types, EGFR overexpression has been associated with poorer prognosis and outcomes. Therapies targeting EGFR include monoclonal antibodies, tyrosine kinase inhibitors, phosphatidylin...
Na minha lista:
| Publicado no: | Cancer Metastasis Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693744/ https://ncbi.nlm.nih.gov/pubmed/28866730 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10555-017-9687-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|